Autologous hematopoietic stem cell transplantation (ASCT) outcomes in non-Hodgkin lymphoma (NHL) patients undergoing high dose therapy (HDT) with etoposide, cyclophosphamide and thiotepa (VP/CY/TT) versus cyclophosphamide, carmustine and etoposide (CBV)

被引：0
|
作者：
Veltri, L. W. [1 ]
Shah, N. [1 ]
Cumpston, A. [1 ]
Zhang, J. [1 ]
Wen, S. [1 ]
Watkins, K. [1 ]
Leadmon, S. [1 ]
Craig, M. [1 ]
Hamadani, M. [2 ]
Kanate, A. S. [1 ]
机构：
[1] W Virginia Univ, Hematol Oncol, Morgantown, WV 26506 USA
[2] Med Coll Wisconsin, Hematol Oncol, Milwaukee, WI 53226 USA
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P237
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [21] Long Term Outcomes of Autologous Hematopoietic Cell Transplant (AHCT) Following Thiotepa-Based High-Dose Therapy (HDT) in Patients with Non-Hodgkin Lymphoma (NHL)
    Shah, Nilay A.
    Rauenzahn, Sherri
    Wen, Sijin
    Craig, Michael
    Kanate, Abraham S.
    Hamadani, Mehdi
    Cumpston, Aaron
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S117 - S117
  • [22] ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN PATIENTS WITH REFRACTORY LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    ATTAL, M
    CANAL, P
    SCHLAIFER, D
    CHATELUT, E
    DEZEUZE, A
    HUGUET, F
    PAYEN, C
    PRIS, J
    LAURENT, G
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 141 - 148
  • [23] ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN REFRACTORY LYMPHOMA PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SCHLAIFER, D
    ATTAL, M
    HUGUET, F
    CANAL, P
    LAURENT, G
    PRIS, J
    SEMINARS IN HEMATOLOGY, 1994, 31 (02) : 31 - 31
  • [24] High dose cyclophosphamide, BCNU, and VP-16 (CBV), as a conditioning regimen for allogenic stem cell transplantation for patients with non-Hodgkin lymphoma.
    Jani, C
    Rossi, HA
    Emmons, RVB
    Becker, PS
    Westervelt, P
    Levy, M
    Liu, Q
    Clark, Y
    Ballen, K
    BLOOD, 2002, 100 (11) : 458B - 458B
  • [25] Autologous hematopoietic stem cell transplantation (ASCT) following high-dose therapy (HDT) for non-Hodgkin's lymphoma (NHL) in adults 60 years of age and older.
    Gopal, A
    Gooley, T
    Golden, J
    Maloney, D
    Bensinger, W
    Petersdorf, S
    Appelbaum, F
    Press, O
    BLOOD, 1999, 94 (10) : 170A - 170A
  • [26] Busulfan, cyclophosphamide, etoposide is not superior to carmustine, etoposide, cytarabine, mephalan conditioning prior to autologous stem cell transplantation in patients with Hodgkin's lymphoma and is associated with increased toxicity
    Salem, G.
    Dunavin, N.
    Wei, L.
    Elder, P.
    Penza, S.
    Blum, K.
    Porcu, P.
    Baiocchi, R.
    Jones, J.
    Flynn, J.
    Andritsos, L.
    Devine, S. M.
    Christian, B.
    Efebera, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S84 - S85
  • [27] Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL)
    Jagadeesh, Deepa
    Rybicki, Lisa
    Abounader, Lonna
    Liu, Hein
    Dean, Robert M.
    Hill, Brian T.
    Sobecks, Ronald M.
    Gerds, Aaron
    Hamilton, Betty Ky
    Pohlman, Brad
    Kalaycio, Matt E.
    Bolwell, Brian
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S224 - S225
  • [28] Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)
    N Shah
    S Rauenzahn
    L Veltri
    S Wen
    M Craig
    M Hamadani
    A S Kanate
    A Cumpston
    Bone Marrow Transplantation, 2017, 52 : 321 - 322
  • [29] Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)
    Shah, N.
    Rauenzahn, S.
    Veltri, L.
    Wen, S.
    Craig, M.
    Hamadani, M.
    Kanate, A. S.
    Cumpston, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (02) : 321 - 322
  • [30] Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma
    Cote, Gregory M.
    Hochberg, Ephraim P.
    Muzikansky, Alona
    Hochberg, Fred H.
    Drappatz, Jan
    McAfee, Steven L.
    Batchelor, Tracy T.
    LaCasce, Ann S.
    Fisher, David C.
    Abramson, Jeremy S.
    Armand, Philippe
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : 76 - 83
12345